ANTIVIRAL THERAPY

The field of antiviral therapy is expanding at an unprecedented rate. The tremendous expansion in drug screening and rational drug design brought about by the HIV pandemic, together with gathering interest in new viral targets' such as the hepatitis and papillomaviruses, means that more antiviral agents than ever are reaching clinical trials. Several journals now deal exclusively with the chemistry, design and pre-clinical development of antiviral agents. Previously, however, publications concerning clinical aspects of antiviral therapy have been dispersed among a wide range of different journals, making it increasingly difficult to keep abreast of this multidisciplinary field. Antiviral Therapy is the first international journal solely devoted to the clinical development and use of antiviral agents. It publishes original scientific papers in all therapeutic areas, including: results of clinical studies in all phases; viral diagnostics and individualization of antiviral therapy; study design issues in the clinical assessment of antivirals; antiviral drug safety and safety monitoring; mechanisms of resistance to antiviral agents; pharmacoepidemiology of viral diseases. Antiviral Therapy also features review articles, editorials, book reviews and a letters section to provide a forum for discussion. Antiviral Therapy is an official publication of the International Society for Antiviral Research

抗病毒治疗领域正以前所未有的速度扩展。艾滋病带来的药物筛选和合理药物设计的巨大扩展，加上对肝炎和乳头状瘤病毒等新的病毒目标的兴趣的聚集，意味着比以往任何时候都更多的抗病毒药物进入了临床试验。一些期刊现在专门讨论抗病毒药物的化学、设计和临床前的发展。然而，以前有关抗病毒治疗的临床方面的出版物分散在各种不同的期刊中，使人们越来越难以跟上这一多学科领域的发展。《抗病毒治疗》是第一个专门用于临床开发和使用抗病毒药物的国际期刊。它出版所有治疗领域的原始科学论文，包括：各阶段的临床研究结果；抗病毒治疗的病毒诊断和个体化；抗病毒药物临床评估中的研究设计问题；抗病毒药物的安全和监测；抗病毒药物抗性机制；病毒疾病的药物流行病学。抗病毒疗法还包括评论文章、社论、书评和信件部分，为讨论提供一个论坛。抗病毒治疗是国际抗病毒研究学会的官方出版物